A Platinum Resistance-Related lncRNA Signature for Risk Classification and Prognosis Prediction in Patients with Serous Ovarian Cancer

Accurate risk stratification for patients with serous ovarian cancer (SOC) is pivotal for treatment decisions. In this study, we identified a lncRNA-based signature for predicting platinum resistance and prognosis stratification for SOC patients. We analyzed the RNA-sequencing data and the relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yan, Chen, Jiongyu, Zhou, Li, Zhang, Lina, Liu, Yuxin, Zhuang, Yixuan, Peng, Lin, Huang, Yi-Teng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202609/
https://www.ncbi.nlm.nih.gov/pubmed/37223641
http://dx.doi.org/10.1155/2022/7625138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202609/
https://www.ncbi.nlm.nih.gov/pubmed/37223641
http://dx.doi.org/10.1155/2022/7625138

Ejemplares similares